(Reuters) - "All things considered, we do not expect to reach a
partnership agreement in the near term," Chief Executive Alfred
Mann said on a conference call with analysts, referring to the
product, Technosphere insulin .
The company's shares were trading almost 15 percent down at
$9.04 in afternoon trade on the Nasdaq. They hit a year low of
$8.56 earlier in the day.
Read more at Reuters.com Government Filings News
partnership agreement in the near term," Chief Executive Alfred
Mann said on a conference call with analysts, referring to the
product, Technosphere insulin .
The company's shares were trading almost 15 percent down at
$9.04 in afternoon trade on the Nasdaq. They hit a year low of
$8.56 earlier in the day.
Read more at Reuters.com Government Filings News
No comments:
Post a Comment